Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful Treatment of Acquired Thrombotic Thrombocytopenic Purpura With Caplacizumab Combined With Plasma Exchanges and Immune Suppression in 3 Children.
Kalinina II, Antonova KS, Avdonin PV, Klebanova EE, Kotskaya NN, Kurnikova EE, Shutova AD, Matveev VE, Maschan AA. Kalinina II, et al. J Pediatr Hematol Oncol. 2024 Apr 1;46(3):e220-e222. doi: 10.1097/MPH.0000000000002843. Epub 2024 Feb 29. J Pediatr Hematol Oncol. 2024. PMID: 38447071 Free PMC article.
[Treatment of thrombotic thrombocytopenic purpura].
Galstyan GM, Maschan AA, Klebanova EE, Kalinina II. Galstyan GM, et al. Among authors: kalinina ii. Ter Arkh. 2021 Jul 23;93(7):826-829. doi: 10.26442/00403660.2021.07.200914. Ter Arkh. 2021. PMID: 36286735 Russian.
[Treatment of thrombotic thrombocytopenic purpura].
Galstyan GM, Maschan AA, Klebanova EE, Kalinina II. Galstyan GM, et al. Among authors: kalinina ii. Ter Arkh. 2021 Jun 15;93(6):736-745. doi: 10.26442/00403660.2021.06.200894. Ter Arkh. 2021. PMID: 36286842 Russian.
Bortezomib induces long-term remission in children with immune thrombotic thrombocytopenic purpura, refractory to plasma exchange, glucocorticoids, and rituximab: A report on two cases.
Maschan A, Petrova U, Kalinina I, Kurnikova E, Fedorova D, Baidildina D, Kotskaya N, Avdonin P, Novichkova G. Maschan A, et al. Pediatr Blood Cancer. 2021 Apr;68(4):e28818. doi: 10.1002/pbc.28818. Epub 2020 Nov 19. Pediatr Blood Cancer. 2021. PMID: 33211391 No abstract available.
Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia.
Goronkova O, Novichkova G, Salimova T, Kalinina I, Baidildina D, Petrova U, Antonova K, Sadovskaya M, Suntsova E, Evseev D, Matveev V, Venyov D, Khachatryan L, Litvinov D, Pshonkin A, Ovsyannikova G, Kotskaya N, Gobadze D, Olshanskaya Y, Popov A, Raykina E, Mironenko O, Voronin K, Purbueva B, Boichenko E, Dinikina Y, Guseynova E, Sherstnev D, Kalinina E, Mezentsev S, Streneva O, Yudina N, Plaksina O, Erega E, Maschan M, Maschan A. Goronkova O, et al. Blood Adv. 2023 Mar 28;7(6):953-962. doi: 10.1182/bloodadvances.2021006716. Blood Adv. 2023. PMID: 35446936 Free PMC article. Clinical Trial.
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
Evseev D, Osipova D, Kalinina I, Raykina E, Ignatova A, Lyudovskikh E, Baidildina D, Popov A, Zhogov V, Semchenkova A, Litvin E, Kotskaya N, Cherniak E, Voronin K, Burtsev E, Bronin G, Vlasova I, Purbueva B, Fink O, Pristanskova E, Dzhukaeva I, Erega E, Novichkova G, Maschan A, Maschan M. Evseev D, et al. Blood Adv. 2023 Sep 26;7(18):5246-5257. doi: 10.1182/bloodadvances.2022009067. Blood Adv. 2023. PMID: 37216396 Free PMC article.
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.
Evseev D, Kalinina I, Raykina E, Osipova D, Abashidze Z, Ignatova A, Mitrofanova A, Maschan A, Novichkova G, Maschan M. Evseev D, et al. Int J Hematol. 2021 Dec;114(6):725-734. doi: 10.1007/s12185-021-03205-8. Epub 2021 Aug 12. Int J Hematol. 2021. PMID: 34383272
44 results